21 CFR § 1304.26 - Additional recordkeeping requirements applicable to drug products containing gamma-hydroxybutyric acid.

---
identifier: "/us/cfr/t21/s1304.26"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 1304.26 - Additional recordkeeping requirements applicable to drug products containing gamma-hydroxybutyric acid."
title_number: 21
title_name: "Food and Drugs"
section_number: "1304.26"
section_name: "Additional recordkeeping requirements applicable to drug products containing gamma-hydroxybutyric acid."
chapter_name: "DRUG ENFORCEMENT ADMINISTRATION, DEPARTMENT OF JUSTICE"
part_number: "1304"
part_name: "RECORDS AND REPORTS OF REGISTRANTS"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 821, 823(j), 827, 831, 871(b), 958(e)-(g), and 965, unless otherwise noted."
cfr_part: "1304"
---


# 1304.26 Additional recordkeeping requirements applicable to drug products containing gamma-hydroxybutyric acid.

In addition to the recordkeeping requirements for dispensers and researchers provided in § 1304.22, practitioners dispensing gamma-hydroxybutyric acid that is manufactured or distributed in accordance with an application under section 505 of the Federal Food, Drug, and Cosmetic Act must maintain and make available for inspection and copying by the Attorney General, all of the following information for each prescription:

(a) Name of the prescribing practitioner.

(b) Prescribing practitioner's Federal and State registration numbers, with the expiration dates of these registrations.

(c) Verification that the prescribing practitioner possesses the appropriate registration to prescribe this controlled substance.

(d) Patient's name and address.

(e) Patient's insurance provider, if available.

[70 FR 293, Jan. 4, 2005]